Table 1.
Distribution of UL146 genotypes in case and control groups
| Genotype | CMV diagnoses | Total case CMV strains | Control CMV strains | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| cCMV | SNHL-CMV | cCMV + SNHL-CMV | |||||||||
| n | f (%) | n | f (%) | n | f (%) | n | f (%) | n | f (%) | ||
| GT1 | 2 | 3.6 | 3 | 7.9 | 0 | 0.0 | 5 | 4.3 | 9 | 10.8 | 0.09 |
| GT2 | 5 | 9.1 | 1 | 2.6 | 3 | 13.0 | 9 | 7.8 | 3 | 3.6 | 0.37 |
| GT3 | 0 | 0.0 | 1 | 2.6 | 1 | 4.3 | 2 | 1.7 | 2 | 2.4 | > 0.99 |
| GT4 | 1 | 1.8 | 1 | 2.6 | 0 | 0.0 | 2 | 1.7 | 2 | 2.4 | > 0.99 |
| GT5 | 1 | 1.8 | 1 | 2.6 | 1 | 4.3 | 3 | 2.6 | 0 | 0.0 | 0.27 |
| GT6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 2.4 | 0.17 |
| GT7 | 5 | 9.1 | 2 | 5.3 | 0 | 0.0 | 7 | 6.0 | 8 | 9.6 | 0.42 |
| GT8 | 7 | 12.7 | 2 | 5.3 | 3 | 13.0 | 12 | 10.3 | 3 | 3.6 | 0.10 |
| GT9 | 7 | 12.7 | 2 | 5.3 | 2 | 8.7 | 11 | 9.5 | 8 | 9.6 | > 0.99 |
| GT10 | 1 | 1.8 | 2 | 5.3 | 0 | 0.0 | 3 | 2.6 | 2 | 2.4 | > 0.99 |
| GT11 | 1 | 1.8 | 3 | 7.9 | 0 | 0.0 | 4 | 3.4 | 3 | 3.6 | > 0.99 |
| GT12 | 14 | 25.5 | 13 | 34.2 | 10 | 43.5 | 37 | 31.9 | 26 | 31.3 | > 0.99 |
| GT13 | 9 | 16.4 | 6 | 15.8 | 3 | 13.0 | 18 | 15.5 | 12 | 14.5 | > 0.99 |
| GT14 | 2 | 3.6 | 1 | 2.6 | 0 | 0.0 | 3 | 2.6 | 3 | 3.6 | 0.70 |
| Total | 55 | 100.0 | 38 | 100.0 | 23 | 100.0 | 116 | 100.0 | 83 | 100.0 | |
P-value calculated using Fisher’s exact test between total observations among CMV cases compared to the controls